Global and Japan Parkinsons disease Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 148
Inquire Before Buying

Parkinsons disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Parkinsons disease Drug market is segmented into

Carbidopa/Levodopa

Dopamine Receptor Agonists

MAO-Inhibitors

Segment by Application, the Parkinsons disease Drug market is segmented into

Hospital

Online

Retail Pharmacies

Regional and Country-level Analysis

The Parkinsons disease Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Parkinsons disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Parkinsons disease Drug Market Share Analysis

Parkinsons disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parkinsons disease Drug business, the date to enter into the Parkinsons disease Drug market, Parkinsons disease Drug product introduction, recent developments, etc.

The major vendors covered:

Teva

Novartis AG

GSK

AbbVie

Merck

Boehringer Ingelheim

Impax Laboratories

Lundbeck

Sun Pharma

Wockhardt

UCB

Bausch Health

Acadia

Global and Japan Parkinsons disease Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Parkinsons disease Drug Product Introduction
1.2 Market Segments
1.3 Key Parkinsons disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Parkinsons disease Drug Market Size Growth Rate by Type
1.4.2 Carbidopa/Levodopa
1.4.3 Dopamine Receptor Agonists
1.4.4 MAO-Inhibitors
1.5 Market by Application
1.5.1 Global Parkinsons disease Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Online
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parkinsons disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Parkinsons disease Drug Revenue 2015-2026
2.1.2 Global Parkinsons disease Drug Sales 2015-2026
2.2 Global Parkinsons disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Parkinsons disease Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Parkinsons disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Parkinsons disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Parkinsons disease Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Parkinsons disease Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Parkinsons disease Drug Revenue Forecast by Region (2021-2026)
3 Global Parkinsons disease Drug Competitor Landscape by Players
3.1 Global Top Parkinsons disease Drug Sales by Manufacturers
3.1.1 Global Parkinsons disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Parkinsons disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Parkinsons disease Drug Manufacturers by Revenue
3.2.1 Global Parkinsons disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Parkinsons disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Parkinsons disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Parkinsons disease Drug Revenue in 2019
3.2.5 Global Parkinsons disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Parkinsons disease Drug Price by Manufacturers
3.4 Global Parkinsons disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Parkinsons disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinsons disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Parkinsons disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parkinsons disease Drug Market Size by Type (2015-2020)
4.1.1 Global Parkinsons disease Drug Sales by Type (2015-2020)
4.1.2 Global Parkinsons disease Drug Revenue by Type (2015-2020)
4.1.3 Parkinsons disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Parkinsons disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Parkinsons disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Parkinsons disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Parkinsons disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Parkinsons disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Parkinsons disease Drug Market Size by Application (2015-2020)
5.1.1 Global Parkinsons disease Drug Sales by Application (2015-2020)
5.1.2 Global Parkinsons disease Drug Revenue by Application (2015-2020)
5.1.3 Parkinsons disease Drug Price by Application (2015-2020)
5.2 Parkinsons disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Parkinsons disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Parkinsons disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Parkinsons disease Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Parkinsons disease Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Parkinsons disease Drug Sales YoY Growth 2015-2026
6.1.2 Japan Parkinsons disease Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Parkinsons disease Drug Market Share in Global Market 2015-2026
6.2 Japan Parkinsons disease Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Parkinsons disease Drug Players by Sales (2015-2020)
6.2.2 Japan Top Parkinsons disease Drug Players by Revenue (2015-2020)
6.3 Japan Parkinsons disease Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Parkinsons disease Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Parkinsons disease Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Parkinsons disease Drug Price by Type (2015-2020)
6.4 Japan Parkinsons disease Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Parkinsons disease Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Parkinsons disease Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Parkinsons disease Drug Price Forecast by Type (2021-2026)
6.5 Japan Parkinsons disease Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Parkinsons disease Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Parkinsons disease Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Parkinsons disease Drug Price by Application (2015-2020)
6.6 Japan Parkinsons disease Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Parkinsons disease Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Parkinsons disease Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Parkinsons disease Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Parkinsons disease Drug Market Size YoY Growth 2015-2026
7.2 North America Parkinsons disease Drug Market Facts & Figures by Country
7.2.1 North America Parkinsons disease Drug Sales by Country (2015-2020)
7.2.2 North America Parkinsons disease Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Parkinsons disease Drug Market Size YoY Growth 2015-2026
8.2 Europe Parkinsons disease Drug Market Facts & Figures by Country
8.2.1 Europe Parkinsons disease Drug Sales by Country
8.2.2 Europe Parkinsons disease Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Parkinsons disease Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Parkinsons disease Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Parkinsons disease Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Parkinsons disease Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Parkinsons disease Drug Market Size YoY Growth 2015-2026
10.2 Latin America Parkinsons disease Drug Market Facts & Figures by Country
10.2.1 Latin America Parkinsons disease Drug Sales by Country
10.2.2 Latin America Parkinsons disease Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Parkinsons disease Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Parkinsons disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Parkinsons disease Drug Sales by Country
11.2.2 Middle East and Africa Parkinsons disease Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Parkinsons disease Drug Products Offered
12.1.5 Teva Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Corporation Information
12.2.2 Novartis AG Description and Business Overview
12.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AG Parkinsons disease Drug Products Offered
12.2.5 Novartis AG Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Parkinsons disease Drug Products Offered
12.3.5 GSK Recent Development
12.4 AbbVie
12.4.1 AbbVie Corporation Information
12.4.2 AbbVie Description and Business Overview
12.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AbbVie Parkinsons disease Drug Products Offered
12.4.5 AbbVie Recent Development
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Description and Business Overview
12.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck Parkinsons disease Drug Products Offered
12.5.5 Merck Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Description and Business Overview
12.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Impax Laboratories
12.7.1 Impax Laboratories Corporation Information
12.7.2 Impax Laboratories Description and Business Overview
12.7.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
12.7.5 Impax Laboratories Recent Development
12.8 Lundbeck
12.8.1 Lundbeck Corporation Information
12.8.2 Lundbeck Description and Business Overview
12.8.3 Lundbeck Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lundbeck Parkinsons disease Drug Products Offered
12.8.5 Lundbeck Recent Development
12.9 Sun Pharma
12.9.1 Sun Pharma Corporation Information
12.9.2 Sun Pharma Description and Business Overview
12.9.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sun Pharma Parkinsons disease Drug Products Offered
12.9.5 Sun Pharma Recent Development
12.10 Wockhardt
12.10.1 Wockhardt Corporation Information
12.10.2 Wockhardt Description and Business Overview
12.10.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Wockhardt Parkinsons disease Drug Products Offered
12.10.5 Wockhardt Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Teva Parkinsons disease Drug Products Offered
12.11.5 Teva Recent Development
12.12 Bausch Health
12.12.1 Bausch Health Corporation Information
12.12.2 Bausch Health Description and Business Overview
12.12.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bausch Health Products Offered
12.12.5 Bausch Health Recent Development
12.13 Acadia
12.13.1 Acadia Corporation Information
12.13.2 Acadia Description and Business Overview
12.13.3 Acadia Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Acadia Products Offered
12.13.5 Acadia Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Parkinsons disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinsons disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Parkinsons disease Drug Market Segments
Table 2. Ranking of Global Top Parkinsons disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Parkinsons disease Drug Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Carbidopa/Levodopa
Table 5. Major Manufacturers of Dopamine Receptor Agonists
Table 6. Major Manufacturers of MAO-Inhibitors
Table 7. Global Parkinsons disease Drug Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Parkinsons disease Drug Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Parkinsons disease Drug Sales by Regions 2015-2020 (K Doses)
Table 10. Global Parkinsons disease Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Parkinsons disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Parkinsons disease Drug Sales Forecast by Region (2021-2026) (K Doses)
Table 13. Global Parkinsons disease Drug Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global Parkinsons disease Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Parkinsons disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Parkinsons disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinsons disease Drug as of 2019)
Table 17. Parkinsons disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Parkinsons disease Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Parkinsons disease Drug Price (2015-2020) (USD/Dose)
Table 20. Parkinsons disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Parkinsons disease Drug Product Type
Table 22. Date of International Manufacturers Enter into Parkinsons disease Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Parkinsons disease Drug Sales by Type (2015-2020) (K Doses)
Table 25. Global Parkinsons disease Drug Sales Share by Type (2015-2020)
Table 26. Global Parkinsons disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Parkinsons disease Drug Revenue Share by Type (2015-2020)
Table 28. Parkinsons disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global Parkinsons disease Drug Sales Share by Type (2021-2026)
Table 30. Global Parkinsons disease Drug Sales by Application (2015-2020) (K Doses)
Table 31. Global Parkinsons disease Drug Sales Share by Application (2015-2020)
Table 32. Global Parkinsons disease Drug Sales Share by Application (2021-2026)
Table 33. Global Parkinsons disease Drug Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Parkinsons disease Drug Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Parkinsons disease Drug Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Parkinsons disease Drug Sales (K Doses) of Key Companies (2015-2020)
Table 37. Japan Parkinsons disease Drug Sales Share by Company (2015-2020)
Table 38. Japan Parkinsons disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 40. Japan Parkinsons disease Drug Sales Share by Type (2015-2020)
Table 41. Japan Parkinsons disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Parkinsons disease Drug Price (K Doses) by Type (2015-2020)
Table 43. Japan Parkinsons disease Drug Sales (K Doses) by Type (2021-2026)
Table 44. Japan Parkinsons disease Drug Sales Share by Type (2021-2026)
Table 45. Japan Parkinsons disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Parkinsons disease Drug Revenue Share by Type (2021-2026)
Table 47. Japan Parkinsons disease Drug Price (K Doses) by Type (2021-2026)
Table 48. Japan Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 49. Japan Parkinsons disease Drug Sales Share by Application (2015-2020)
Table 50. Japan Parkinsons disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Parkinsons disease Drug Sales (K Doses) by Application (2021-2026)
Table 52. Japan Parkinsons disease Drug Sales Share by Application (2021-2026)
Table 53. Japan Parkinsons disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Parkinsons disease Drug Revenue Share by Application (2021-2026)
Table 55. North America Parkinsons disease Drug Sales by Country (2015-2020) (K Doses)
Table 56. North America Parkinsons disease Drug Sales Market Share by Country (2015-2020)
Table 57. North America Parkinsons disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Parkinsons disease Drug Revenue Market Share by Country (2015-2020)
Table 59. Europe Parkinsons disease Drug Sales by Country (2015-2020) (K Doses)
Table 60. Europe Parkinsons disease Drug Sales Market Share by Country (2015-2020)
Table 61. Europe Parkinsons disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Parkinsons disease Drug Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Parkinsons disease Drug Sales by Region (2015-2020) (K Doses)
Table 64. Asia Pacific Parkinsons disease Drug Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Parkinsons disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Parkinsons disease Drug Revenue Market Share by Region (2015-2020)
Table 67. Latin America Parkinsons disease Drug Sales by Country (2015-2020) (K Doses)
Table 68. Latin America Parkinsons disease Drug Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Parkinsons disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Parkinsons disease Drug Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Parkinsons disease Drug Sales by Country (2015-2020) (K Doses)
Table 72. Middle East and Africa Parkinsons disease Drug Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Parkinsons disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Parkinsons disease Drug Revenue Market Share by Country (2015-2020)
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Teva Parkinsons disease Drug Product
Table 79. Teva Recent Development
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Novartis AG Product
Table 84. Novartis AG Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GSK Product
Table 89. GSK Recent Development
Table 90. AbbVie Corporation Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. AbbVie Product
Table 94. AbbVie Recent Development
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Merck Product
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Boehringer Ingelheim Product
Table 104. Boehringer Ingelheim Recent Development
Table 105. Impax Laboratories Corporation Information
Table 106. Impax Laboratories Description and Business Overview
Table 107. Impax Laboratories Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Impax Laboratories Product
Table 109. Impax Laboratories Recent Development
Table 110. Lundbeck Corporation Information
Table 111. Lundbeck Description and Business Overview
Table 112. Lundbeck Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Lundbeck Product
Table 114. Lundbeck Recent Development
Table 115. Sun Pharma Corporation Information
Table 116. Sun Pharma Description and Business Overview
Table 117. Sun Pharma Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Sun Pharma Product
Table 119. Sun Pharma Recent Development
Table 120. Wockhardt Corporation Information
Table 121. Wockhardt Description and Business Overview
Table 122. Wockhardt Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Wockhardt Product
Table 124. Wockhardt Recent Development
Table 125. UCB Corporation Information
Table 126. UCB Description and Business Overview
Table 127. UCB Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. UCB Product
Table 129. UCB Recent Development
Table 130. Bausch Health Corporation Information
Table 131. Bausch Health Description and Business Overview
Table 132. Bausch Health Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Bausch Health Product
Table 134. Bausch Health Recent Development
Table 135. Acadia Corporation Information
Table 136. Acadia Description and Business Overview
Table 137. Acadia Parkinsons disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Acadia Product
Table 139. Acadia Recent Development
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Parkinsons disease Drug Players
Table 144. Parkinsons disease Drug Customers List
Table 145. Parkinsons disease Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons disease Drug Product Picture
Figure 2. Global Parkinsons disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Carbidopa/Levodopa Product Picture
Figure 4. Dopamine Receptor Agonists Product Picture
Figure 5. MAO-Inhibitors Product Picture
Figure 6. Global Parkinsons disease Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Online
Figure 9. Retail Pharmacies
Figure 10. Parkinsons disease Drug Report Years Considered
Figure 11. Global Parkinsons disease Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Parkinsons disease Drug Sales 2015-2026 (K Doses)
Figure 13. Global Parkinsons disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Parkinsons disease Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Parkinsons disease Drug Sales Market Share by Region in 2019
Figure 16. Global Parkinsons disease Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Parkinsons disease Drug Revenue Market Share by Region in 2019
Figure 18. Global Parkinsons disease Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Parkinsons disease Drug Revenue in 2019
Figure 20. Parkinsons disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 23. Global Parkinsons disease Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Parkinsons disease Drug Revenue Market Share by Type in 2019
Figure 25. Global Parkinsons disease Drug Market Share by Price Range (2015-2020)
Figure 26. Global Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 28. Global Parkinsons disease Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Parkinsons disease Drug Revenue Market Share by Application in 2019
Figure 30. Japan Parkinsons disease Drug Sales Growth Rate 2015-2026 (K Doses)
Figure 31. Japan Parkinsons disease Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Japan Parkinsons disease Drug Market Share in Global Market 2015-2026
Figure 33. Japan 5 and 10 Largest Parkinsons disease Drug Players Market Share by Revenue in Parkinsons disease Drug in 2019
Figure 34. Japan Parkinsons disease Drug Revenue Share by Type (2015-2020)
Figure 35. Japan Parkinsons disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Japan Parkinsons disease Drug Revenue Share by Application (2015-2020)
Figure 37. Japan Parkinsons disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Parkinsons disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 39. North America Parkinsons disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Parkinsons disease Drug Sales Market Share by Country in 2019
Figure 41. North America Parkinsons disease Drug Revenue Market Share by Country in 2019
Figure 42. U.S. Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 43. U.S. Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Canada Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Parkinsons disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 47. Europe Parkinsons disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Parkinsons disease Drug Sales Market Share by Country in 2019
Figure 49. Europe Parkinsons disease Drug Revenue Market Share by Country in 2019
Figure 50. Germany Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Germany Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 53. France Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 55. U.K. Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Parkinsons disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Parkinsons disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Parkinsons disease Drug Sales Market Share by Region in 2019
Figure 63. Asia Pacific Parkinsons disease Drug Revenue Market Share by Region in 2019
Figure 64. China Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Parkinsons disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 87. Latin America Parkinsons disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Parkinsons disease Drug Sales Market Share by Country in 2019
Figure 89. Latin America Parkinsons disease Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Mexico Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Brazil Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Argentina Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Parkinsons disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Parkinsons disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Parkinsons disease Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Parkinsons disease Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Parkinsons disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Parkinsons disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Parkinsons disease Drug Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executi
  • Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 141
    Parkinson's Disease (PD) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease (PD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Parkinson's......
  • (COVID-19 Version) Global Parkinson's Disease Therapeutics Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Oct-2020        Price: US 3000 Onwards        Pages: 110
    Summary The report forecast global Parkinson's Disease Therapeutics market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Parkinson's Disease Therapeutics industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pa......
  • Global and Japan Parkinson's Disease Drug Market Insights, Forecast to 2026
    Published: 21-Oct-2020        Price: US 3900 Onwards        Pages: 148
    Parkinson's Disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Parkinson's Disease Dru......
  • (COVID-19 Version) Global Rasagiline Tablet Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 19-Oct-2020        Price: US 3000 Onwards        Pages: 87
    Summary The report forecast global Rasagiline Tablet market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Rasagiline Tablet industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Rasagiline Tablet by geography. ......
  • COVID-19 World Rasagiline Tablet Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 17-Oct-2020        Price: US 2800 Onwards        Pages: 106
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Rasagiline Tablet , covering Global tota......
  • Global and Japan Parkinsons disease Drug Market Insights, Forecast to 2026
    Published: 15-Oct-2020        Price: US 3900 Onwards        Pages: 148
    Parkinsons disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Parkinsons disease Drug m......
  • (COVID-19 Version) Global Parkinson's Disease Drug Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 20-Sep-2020        Price: US 3000 Onwards        Pages: 124
    Summary The report forecast global Parkinson's Disease Drug market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Parkinson's Disease Drug industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Parkinson's Diseas......
  • Global and Japan Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 02-Sep-2020        Price: US 3900 Onwards        Pages: 128
    Global Parkinson's Disease Therapeutics Scope and Market Size Parkinson's Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market seg......
  • COVID-19 World Parkinson's Disease Drug Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 02-Sep-2020        Price: US 2800 Onwards        Pages: 125
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Parkinson's Disease Drug , covering Glob......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs